NASDAQ · WALD
Technology · Software - Application
$0.88
Up+$0.00 (+0.00%)
Updated Oct 6, 2026, 9:38 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · WALD
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
WALD closed at $0.88 after 19 trading sessions, down 31.83% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $0.93 | $0.99 | $0.861 | $0.8794 | 277.02K |
| Oct 1, 2026 | $0.84 | $0.9639 | $0.84 | $0.9227 | 305.02K |
| Sep 30, 2026 | $0.9277 | $0.9713 | $0.82 | $0.8595 | 289.92K |
| Sep 29, 2026 | $1.02 | $1.055 | $0.9171 | $0.9277 | 287.91K |
| Sep 28, 2026 | $1.01 | $1.065 | $1.01 | $1.06 | 265.58K |
| Sep 25, 2026 | $1.01 | $1.05 | $0.9801 | $1.03 | 277.61K |
| Sep 24, 2026 | $1.01 | $1.05 | $0.975 | $1.03 | 325.16K |
| Sep 23, 2026 | $1.05 | $1.13 | $0.983 | $1.02 | 193.93K |
| Sep 22, 2026 | $1.10 | $1.12 | $1.07 | $1.07 | 573.77K |
| Sep 21, 2026 | $1.14 | $1.14 | $1.07 | $1.10 | 502K |
| Sep 18, 2026 | $1.15 | $1.16 | $1.125 | $1.16 | 360.69K |
| Sep 17, 2026 | $1.14 | $1.18 | $1.0701 | $1.15 | 360.34K |
| Sep 16, 2026 | $1.09 | $1.18 | $1.07 | $1.14 | 287.4K |
| Sep 15, 2026 | $1.13 | $1.16 | $1.075 | $1.12 | 151.18K |
| Sep 14, 2026 | $1.15 | $1.18 | $1.05 | $1.18 | 2.75M |
| Sep 11, 2026 | $1.36 | $1.36 | $1.30 | $1.31 | 39.05K |
| Sep 10, 2026 | $1.31 | $1.36 | $1.305 | $1.33 | 76.4K |
| Sep 9, 2026 | $1.33 | $1.375 | $1.305 | $1.33 | 130.13K |
| Sep 8, 2026 | $1.36 | $1.38 | $1.28 | $1.29 | 128.2K |
The latest Smart Investors Daily articles mentioning WALD.
Company
Market Activity
Research & News
WALD research
Company profile and research snapshot.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 2, 2026 | Canaccord Genuity | Buy | — |
| Mar 16, 2026 | Telsey Advisory Group | Market Perform | — |
| Mar 16, 2026 | Canaccord Genuity | Buy | — |
| Nov 25, 2025 | Canaccord Genuity | Buy | — |
| Nov 25, 2025 | Telsey Advisory Group | Market Perform | — |
No generated briefing is available yet.
Benzinga · Sep 28, 2026
Waldencast (NASDAQ:WALD) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.13) by 476.92 percent. This is a 92.31 percent decrease over losses of $(0.39) per share from
Benzinga · Sep 24, 2026
Waldencast plc (NASDAQ: WALD) ("Waldencast" or the "Company") today announced that it has filed a Form 25 (Notification of Removal from Listing) with the Securities and Exchange Commission (the
Benzinga · Sep 14, 2026
Board to recommend that shareholders approve renaming the Company Milk Makeup plcThe Company’s Board of Directors has approved the voluntary delisting of the Company’s Class A Ordinary Shares and Warrants from Nasdaq
Benzinga · Jun 15, 2026
Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration ("FDA") has approved Obagi® saypha®
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning WALD.
No results
No recent SID articles mention WALD.
